Vertex Pharmaceuticals Inc (VRTX)
Debt-to-capital ratio
Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long-term debt | US$ in thousands | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Total stockholders’ equity | US$ in thousands | 17,580,400 | 16,512,800 | 15,470,200 | 14,432,300 | 13,912,700 | 13,029,600 | 11,933,500 | 10,907,000 | 10,100,000 | 9,530,800 | 9,196,400 | 8,980,300 | 8,686,800 | 8,133,470 | 7,519,240 | 6,461,650 | 6,085,200 | 5,253,390 | 5,069,960 | 4,723,310 |
Debt-to-capital ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
December 31, 2023 calculation
Debt-to-capital ratio = Long-term debt ÷ (Long-term debt + Total stockholders’ equity)
= $—K ÷ ($—K + $17,580,400K)
= 0.00
The debt-to-capital ratio of Vertex Pharmaceuticals, Inc. has shown a relatively stable trend over the past eight quarters. The ratio has been consistently low, ranging between 0.02 to 0.04 during this period. This indicates that the company has a conservative approach to debt financing, relying more on equity to fund its operations and growth. A low debt-to-capital ratio suggests that Vertex Pharmaceuticals has a strong financial position with a lower level of debt in relation to its total capital. Overall, the company's consistent low debt-to-capital ratio reflects sound financial management and a relatively low risk of financial distress related to debt obligations.
Peer comparison
Dec 31, 2023